Table 1.
Cytokines involved in osteoclastogenesis
Cytokine | Main producer cells | Primary target in osteoclastogenesis | Effect on osteoclastogenesis | Role in osteoimmunology |
---|---|---|---|---|
RANKL | T-cells; Osteoblasts | Osteoclast precursor cells | Activation | Induction of osteoclast differentiation |
TNF-α | Macrophages; Th1 cells | Osteoclast precursor cells; mesenchymal cells | Activation | RANKL induction on mesenchymal cells, RANKL synergy, inflammation |
IL-6 | Th2 cells; dendritic cells | Mesenchymal cells; T cells | Activation | RANKL induction on mesenchymal cells, Th17-cell differentiation, inflammation |
IL-17 | Th17 cells; memory T cells | Mesenchymal cells | Activation | RANKL induction on mesenchymal cells, inflammation |
IFN-γ | Th1 cells; natural killer cells | Osteoclast precursor cells | Inhibition | RANKL signaling inhibition, cellular immunity |
IL-4 | Th2 cells; natural killer T cells | Osteoclast precursor cells | Inhibition | RANKL signaling inhibition, humoral immunity |
IL-10 | Th2 cells | Osteoclast precursor cells | Inhibition | RANKL signaling inhibition, antiinflammatory |
IL-12 | Macrophages; dendritic cells | T cells | Inhibition | Th1-cell differentiation, IFN-γ and GM-CSF induction |
IL-18 | Macrophages; dendritic cells | T cells | Inhibition | Th1-cell differentiation, IFN-γ induction |
GM-CSF | Th1 cells | Osteoclast precursor cells | Inhibition | RANKL signaling inhibition, granulocyte differentiation |
GM-CSF granulocyte–macrophage colony-stimulating factor, IFN interferon, IL, interleukin, RANKL receptor activator of nuclear factor-κB ligand, Th T-helper, TNF tumor necrosis factor